Real-world patient insights and engagement
Blue Charm’s integrated digital health and co-pay card programs deliver data that is:
- Geographically and demographically diverse
- Longitudinal across a large patient base
- Real-time and actionable
- Visible at the brand-level
Our process
Unlocking insights to improve outcomes
Recruit patients
We start by recruiting patients who are interested in participating in Blue Charm’s disease-focused journeys. Through a multi-channel recruitment strategy, we identify and enroll patients who can provide valuable insights into their condition and treatment.
Engage patients
Once patients are enrolled in our app, we engage them with personalized learning modules and resources that help them navigate their disease journey. Our engagement approach is designed to keep patients motivated and invested in their treatment, while also capturing valuable data and feedback.
Reward patients
As patients progress through their Blue Charm journey, we incentivize them for their participation in completing modules and surveys.
Capture insights
Throughout the patient journey, we capture a wide range of data and insights that are critical to understanding the patient experience. Our platform uses advanced analytics and reporting tools to provide life sciences companies with actionable insights that inform commercial strategy, market access, medical affairs, and patient support strategies.
Case Study: Asthma
Our solutions
Disease area data subscription
Gain visibility into the real-world experience of patients.
Integrated co-pay card program
Understand the “why” behind your claims data.
Use cases
Learn how our customers are using Blue Charm real-world evidence to address unmet patient needs and improve outcomes.
Commercial
- How does the decision criteria to initiate therapy differ by province?
- What percentage of patients felt like their disease was better managed after switching to Drug A?
Medical Affairs
- Which age group experiences the greatest impact of Drug A on disease progression?
- How does Drug A compare to Drug B on negative side effects?
Patient Services
- What part of the PSP is least important to MS patients?
- What additional PSP service would be most valued by patients in British Columbia?
Market Access
- What’s the public/private/cash payer split for Drug A in Ontario?
- How do co-pay amounts differ between patients with public vs. private plans?
See Blue Charm in action
Book a 25-minute demo with our commercial team